The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Edaravone Injection Market Research Report 2025
Synopsis
Edaravone, sold as under the brand names Radicava and Radicut, is an intravenous medication used to help with recovery following a stroke[1] and to treat amyotrophic lateral sclerosis (ALS).
The global Edaravone Injection market was valued at US$ 246 million in 2023 and is anticipated to reach US$ 496 million by 2030, witnessing a CAGR of 10.0% during the forecast period 2024-2030.
The Radicava market is driven by the need for effective treatments for amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease. Radicava, containing edaravone, is an intravenous medication that has been shown to slow the decline in physical function in ALS patients. The drug's approval and positive clinical outcomes have led to its increasing adoption in ALS management. However, challenges include the high cost of the medication, the need for ongoing treatment, and access barriers in certain regions. Overcoming these challenges through affordability measures, patient support programs, and continued research to better understand and treat ALS will be crucial for the sustained growth of the Radicava market.
This report aims to provide a comprehensive presentation of the global market for Edaravone Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Edaravone Injection.
Report Scope
The Edaravone Injection market size, estimations, and forecasts are provided in terms of sales volume (K Unit) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Edaravone Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Edaravone Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Mitsubishi Tanabe Pharma
Segment by Type
20ml
100ml
Segment by Application
Hospital
Pharmacy
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Edaravone Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Edaravone Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Edaravone, sold as under the brand names Radicava and Radicut, is an intravenous medication used to help with recovery following a stroke[1] and to treat amyotrophic lateral sclerosis (ALS).
The global Edaravone Injection market was valued at US$ 246 million in 2023 and is anticipated to reach US$ 496 million by 2030, witnessing a CAGR of 10.0% during the forecast period 2024-2030.
The Radicava market is driven by the need for effective treatments for amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease. Radicava, containing edaravone, is an intravenous medication that has been shown to slow the decline in physical function in ALS patients. The drug's approval and positive clinical outcomes have led to its increasing adoption in ALS management. However, challenges include the high cost of the medication, the need for ongoing treatment, and access barriers in certain regions. Overcoming these challenges through affordability measures, patient support programs, and continued research to better understand and treat ALS will be crucial for the sustained growth of the Radicava market.
This report aims to provide a comprehensive presentation of the global market for Edaravone Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Edaravone Injection.
Report Scope
The Edaravone Injection market size, estimations, and forecasts are provided in terms of sales volume (K Unit) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Edaravone Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Edaravone Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Mitsubishi Tanabe Pharma
Segment by Type
20ml
100ml
Segment by Application
Hospital
Pharmacy
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Edaravone Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Edaravone Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Edaravone Injection Market Overview
1.1 Product Overview and Scope of Edaravone Injection
1.2 Edaravone Injection Segment by Type
1.2.1 Global Edaravone Injection Market Value Comparison by Type (2024-2030)
1.2.2 20ml
1.2.3 100ml
1.3 Edaravone Injection Segment by Application
1.3.1 Global Edaravone Injection Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Edaravone Injection Market Size Estimates and Forecasts
1.4.1 Global Edaravone Injection Revenue 2019-2030
1.4.2 Global Edaravone Injection Sales 2019-2030
1.4.3 Global Edaravone Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Edaravone Injection Market Competition by Manufacturers
2.1 Global Edaravone Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Edaravone Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Edaravone Injection Average Price by Manufacturers (2019-2024)
2.4 Global Edaravone Injection Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Edaravone Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Edaravone Injection, Product Type & Application
2.7 Edaravone Injection Market Competitive Situation and Trends
2.7.1 Edaravone Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Edaravone Injection Players Market Share by Revenue
2.7.3 Global Edaravone Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Edaravone Injection Retrospective Market Scenario by Region
3.1 Global Edaravone Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Edaravone Injection Global Edaravone Injection Sales by Region: 2019-2030
3.2.1 Global Edaravone Injection Sales by Region: 2019-2024
3.2.2 Global Edaravone Injection Sales by Region: 2025-2030
3.3 Global Edaravone Injection Global Edaravone Injection Revenue by Region: 2019-2030
3.3.1 Global Edaravone Injection Revenue by Region: 2019-2024
3.3.2 Global Edaravone Injection Revenue by Region: 2025-2030
3.4 North America Edaravone Injection Market Facts & Figures by Country
3.4.1 North America Edaravone Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Edaravone Injection Sales by Country (2019-2030)
3.4.3 North America Edaravone Injection Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Edaravone Injection Market Facts & Figures by Country
3.5.1 Europe Edaravone Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Edaravone Injection Sales by Country (2019-2030)
3.5.3 Europe Edaravone Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Edaravone Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Edaravone Injection Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Edaravone Injection Sales by Country (2019-2030)
3.6.3 Asia Pacific Edaravone Injection Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Edaravone Injection Market Facts & Figures by Country
3.7.1 Latin America Edaravone Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Edaravone Injection Sales by Country (2019-2030)
3.7.3 Latin America Edaravone Injection Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Edaravone Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Edaravone Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Edaravone Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Edaravone Injection Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Edaravone Injection Sales by Type (2019-2030)
4.1.1 Global Edaravone Injection Sales by Type (2019-2024)
4.1.2 Global Edaravone Injection Sales by Type (2025-2030)
4.1.3 Global Edaravone Injection Sales Market Share by Type (2019-2030)
4.2 Global Edaravone Injection Revenue by Type (2019-2030)
4.2.1 Global Edaravone Injection Revenue by Type (2019-2024)
4.2.2 Global Edaravone Injection Revenue by Type (2025-2030)
4.2.3 Global Edaravone Injection Revenue Market Share by Type (2019-2030)
4.3 Global Edaravone Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Edaravone Injection Sales by Application (2019-2030)
5.1.1 Global Edaravone Injection Sales by Application (2019-2024)
5.1.2 Global Edaravone Injection Sales by Application (2025-2030)
5.1.3 Global Edaravone Injection Sales Market Share by Application (2019-2030)
5.2 Global Edaravone Injection Revenue by Application (2019-2030)
5.2.1 Global Edaravone Injection Revenue by Application (2019-2024)
5.2.2 Global Edaravone Injection Revenue by Application (2025-2030)
5.2.3 Global Edaravone Injection Revenue Market Share by Application (2019-2030)
5.3 Global Edaravone Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Mitsubishi Tanabe Pharma
6.1.1 Mitsubishi Tanabe Pharma Corporation Information
6.1.2 Mitsubishi Tanabe Pharma Description and Business Overview
6.1.3 Mitsubishi Tanabe Pharma Edaravone Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Mitsubishi Tanabe Pharma Edaravone Injection Product Portfolio
6.1.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Edaravone Injection Industry Chain Analysis
7.2 Edaravone Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Edaravone Injection Production Mode & Process
7.4 Edaravone Injection Sales and Marketing
7.4.1 Edaravone Injection Sales Channels
7.4.2 Edaravone Injection Distributors
7.5 Edaravone Injection Customers
8 Edaravone Injection Market Dynamics
8.1 Edaravone Injection Industry Trends
8.2 Edaravone Injection Market Drivers
8.3 Edaravone Injection Market Challenges
8.4 Edaravone Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
